Chevy Chase Trust Holdings LLC Boosts Stock Holdings in The Cooper Companies, Inc. $COO

Chevy Chase Trust Holdings LLC grew its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 0.8% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 105,725 shares of the medical device company’s stock after purchasing an additional 857 shares during the quarter. Chevy Chase Trust Holdings LLC owned approximately 0.05% of Cooper Companies worth $7,523,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in the company. Horizon Investments LLC increased its holdings in shares of Cooper Companies by 5.0% during the 1st quarter. Horizon Investments LLC now owns 2,859 shares of the medical device company’s stock valued at $241,000 after purchasing an additional 136 shares in the last quarter. Axxcess Wealth Management LLC grew its stake in Cooper Companies by 1.9% in the 1st quarter. Axxcess Wealth Management LLC now owns 7,382 shares of the medical device company’s stock valued at $623,000 after acquiring an additional 140 shares during the period. Exchange Traded Concepts LLC grew its stake in Cooper Companies by 16.3% in the 1st quarter. Exchange Traded Concepts LLC now owns 1,502 shares of the medical device company’s stock valued at $127,000 after acquiring an additional 210 shares during the period. Wealth Alliance LLC grew its stake in Cooper Companies by 5.5% in the 1st quarter. Wealth Alliance LLC now owns 4,059 shares of the medical device company’s stock valued at $342,000 after acquiring an additional 210 shares during the period. Finally, EverSource Wealth Advisors LLC grew its stake in Cooper Companies by 3.5% in the 1st quarter. EverSource Wealth Advisors LLC now owns 6,517 shares of the medical device company’s stock valued at $550,000 after acquiring an additional 220 shares during the period. 24.39% of the stock is owned by hedge funds and other institutional investors.

Cooper Companies Trading Up 4.2%

Shares of COO opened at $74.99 on Tuesday. The Cooper Companies, Inc. has a 52-week low of $61.78 and a 52-week high of $109.04. The company has a quick ratio of 1.24, a current ratio of 2.12 and a debt-to-equity ratio of 0.29. The firm’s fifty day moving average is $69.60 and its two-hundred day moving average is $73.19. The stock has a market cap of $14.91 billion, a PE ratio of 36.94, a price-to-earnings-growth ratio of 1.89 and a beta of 1.02.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Wednesday, August 27th. The medical device company reported $1.10 earnings per share for the quarter, beating the consensus estimate of $1.07 by $0.03. The firm had revenue of $1.06 billion for the quarter, compared to analysts’ expectations of $1.06 billion. Cooper Companies had a net margin of 10.08% and a return on equity of 9.82%. The company’s revenue was up 5.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.96 EPS. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. Research analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies declared that its Board of Directors has authorized a stock repurchase plan on Wednesday, September 17th that permits the company to buyback $2.00 billion in outstanding shares. This buyback authorization permits the medical device company to buy up to 15.4% of its shares through open market purchases. Shares buyback plans are generally an indication that the company’s management believes its stock is undervalued.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on COO shares. Wells Fargo & Company dropped their price target on shares of Cooper Companies from $93.00 to $72.00 and set an “overweight” rating on the stock in a research note on Thursday, August 28th. Weiss Ratings reissued a “hold (c-)” rating on shares of Cooper Companies in a research note on Wednesday, October 8th. Mizuho dropped their price target on shares of Cooper Companies from $105.00 to $90.00 and set an “outperform” rating on the stock in a research note on Wednesday, July 16th. BNP Paribas Exane raised shares of Cooper Companies from a “neutral” rating to an “outperform” rating and set a $92.00 price target on the stock in a research note on Tuesday, July 22nd. Finally, Stifel Nicolaus lowered their target price on shares of Cooper Companies from $90.00 to $85.00 and set a “buy” rating on the stock in a research note on Thursday, August 28th. One investment analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, Cooper Companies presently has an average rating of “Moderate Buy” and a consensus target price of $84.77.

Insider Activity

In other news, COO Daniel G. Mcbride purchased 3,000 shares of the stock in a transaction dated Tuesday, September 2nd. The shares were purchased at an average price of $65.04 per share, with a total value of $195,120.00. Following the transaction, the chief operating officer owned 63,120 shares in the company, valued at $4,105,324.80. The trade was a 4.99% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Lawrence Erik Kurzius purchased 2,000 shares of the stock in a transaction dated Monday, September 29th. The shares were purchased at an average cost of $68.39 per share, for a total transaction of $136,780.00. Following the transaction, the director owned 5,777 shares in the company, valued at approximately $395,089.03. The trade was a 52.95% increase in their position. The disclosure for this purchase can be found here. In the last 90 days, insiders have acquired 17,975 shares of company stock worth $1,216,346. Insiders own 1.98% of the company’s stock.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.